Development of a Virtual Human for Supporting Tobacco Cessation During the COVID-19 Pandemic.

AI COVID-19 artificial intelligence chatbot conversational agent digital health intervention eHealth mobile phone public health smoking cessation tobacco cessation virtual health worker virtual human web-based health

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
05 Dec 2023
Historique:
received: 04 09 2022
accepted: 12 10 2023
revised: 16 02 2023
medline: 7 12 2023
pubmed: 5 12 2023
entrez: 5 12 2023
Statut: epublish

Résumé

People who consume tobacco are at greater risk of developing severe COVID-19. Unfortunately, the COVID-19 pandemic reduced the accessibility of tobacco cessation services as a result of necessary social restrictions. Innovations were urgently needed to support tobacco cessation during the pandemic. Virtual humans are artificially intelligent computer agents with a realistic, humanlike appearance. Virtual humans could be a scalable and engaging way to deliver tobacco cessation information and support. Florence, a virtual human health worker, was developed in collaboration with the World Health Organization to remotely support people toward tobacco cessation during the COVID-19 pandemic. Florence delivers evidence-based information, assists with making quit plans, and directs people to World Health Organization-recommended cessation services in their country. In this viewpoint, we describe the process of developing Florence. The development was influenced by a formative evaluation of data from 115 early users of Florence from 49 countries. In general, Florence was positively perceived; however, changes were requested to aspects of her design and content. In addition, areas for new content were identified (eg, for nonsmoker support persons). Virtual health workers could expand the reach of evidence-based tobacco cessation information and personalized support. However, as they are a new innovation in tobacco cessation, their efficacy, feasibility, and acceptability in this application needs to be evaluated, including in diverse populations.

Identifiants

pubmed: 38051571
pii: v25i1e42310
doi: 10.2196/42310
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e42310

Informations de copyright

©Kate Loveys, Erica Lloyd, Mark Sagar, Elizabeth Broadbent. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.12.2023.

Auteurs

Kate Loveys (K)

Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand.
Soul Machines, Auckland, New Zealand.

Erica Lloyd (E)

Soul Machines, Auckland, New Zealand.

Mark Sagar (M)

Soul Machines, Auckland, New Zealand.
Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.

Elizabeth Broadbent (E)

Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH